Table 3.
Summary of Risk Score Distributions and Observed Risk in INOCA Women
| Model | No. | Risk Score, Median (Range) | Recalibrated Score, Median (Range) | Observed Event Count, n (%) | Follow‐Up Years, Median (Range) |
|---|---|---|---|---|---|
| RRS (MI, stroke, coronary revascularization, cardiovascular death) | 346 | 2.24 (0—50.1) | 8.06 (0, 59.01) | 58 (16.76) | 8.40 (0—10) |
| FRS CVD (angina hospitalization, MI, stroke, CHF, cardiovascular death) | 433 | 4.99 (0—50.26) | 21.38 (0.02, 56.95) | 125 (28.87) | 6.13 (0.01—10) |
| ASCVD (MI, stroke, cardiovascular death) | 433 | 0.04 (0—34.13) | 9.89 (0.01, 22.87) | 44 (10.16) | 8.45 (0.01—10) |
| SCORE (cardiovascular death) | 433 | 0.89 (0—20.56) | ··· | 24 (5.54) | 8.57 (0.01—10) |
| ATP III‐FRS (MI, cardiovascular death) | 433 | 1.63 (0—29.34) | ··· | 29 (6.70) | 8.53 (0.01—10) |
| QRISK2 (angina hospitalization, MI, stroke) | 433 | 5.29 (0.01—41.43) | ··· | 104 (24.02) | 5.50 (0.01—9) |
ASCVD indicates Atherosclerotic Cardiovascular Disease risk score; ATP III‐FRS, Adult Treatment Panel III risk score; CHF, congestive heart failure; CVD, cardiovascular disease; FRS, Framingham Risk Score; hsCRP, high sensitive C reactive protein; INOCA, ischemia and no obstructive coronary artery disease; MI, myocardial infarction; QRISK2, Cardiovascular Disease Risk Algorithm Version 2; RRS, Reynolds Risk Score; and SCORE, Systematic Coronary Risk Evaluation.